Literature DB >> 9805595

A review of comorbidity: major mental illness and problematic substance use.

N Siegfried1.   

Abstract

OBJECTIVE: The aim of this paper is to critically review the literature on major mental illness and problematic substance use in order to provide clinicians and policy-makers with evidence to support proposed directions for management of the above.
METHOD: The available literature was accessed using computerised databases and manual searching.
RESULTS: The predominantly North American-based literature is largely descriptive. Those studies which attempt empirical evaluation are limited by methodological weaknesses which include small sample sizes, short follow-up periods, inadequate measurement of substance use, lack of experimental design, and treatment drift over time. However, there is consensus among most studies regarding prevalence rates and treatment.
CONCLUSIONS: Problematic substance use is the most common comorbid condition among people with a major mental illness and is associated with poorer patient outcomes. There is evidence to suggest that the integration of mental health and drug and alcohol services will result in improved detection, assessment and management of comorbidity. Integration refers to the provision of comprehensive services by a single service with staff who are competent in both mental health and drug and alcohol skills. A tolerant, non-confrontational approach to substance use is most appropriate for people with a major mental illness. Treatment programs need to recognise the longitudinal nature of substance abuse and dependence. More research needs to be conducted in this field in order to establish guidelines for effective management.

Entities:  

Mesh:

Year:  1998        PMID: 9805595     DOI: 10.3109/00048679809113127

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  11 in total

1.  The long-term treatment outcomes of depression and anxiety comorbid with substance abuse.

Authors:  G Bovasso
Journal:  J Behav Health Serv Res       Date:  2001-02       Impact factor: 1.505

2.  Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: the Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 Weeks (LSUR-12) Instruments.

Authors:  Claire E Ramsay; Glen R Abedi; John D Marson; Michael T Compton
Journal:  J Psychiatr Res       Date:  2010-05-20       Impact factor: 4.791

3.  Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families.

Authors:  Jason C Ehret; Patricia S Day; Ryan Wiegand; Joanne Wojcieszek; R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

4.  Structural models of the comorbidity of internalizing disorders and substance use disorders in a longitudinal birth cohort.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-09       Impact factor: 4.328

5.  Social networks of people with dual diagnosis: the quantity and quality of relationships at different stages of substance use treatment.

Authors:  Elspeth M MacDonald; Marni Luxmoore; Simone Pica; Chris Tanti; Janne-Maree Blackman; Neil Catford; Peter Stockton
Journal:  Community Ment Health J       Date:  2004-10

6.  Management of "dual diagnosis" patients : consensus, controversies and considerations.

Authors:  D Basu; N Gupta
Journal:  Indian J Psychiatry       Date:  2000-01       Impact factor: 1.759

7.  Predictors of quality of life in a longitudinal study of users with severe mental disorders.

Authors:  Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Jacques Tremblay; Norbert Schmitz; Jean Caron
Journal:  Health Qual Life Outcomes       Date:  2013-06-08       Impact factor: 3.186

8.  Frequent alcohol, nicotine or cannabis use is common in young persons presenting for mental healthcare: a cross-sectional study.

Authors:  Daniel F Hermens; Elizabeth M Scott; Django White; Marta Lynch; Jim Lagopoulos; Bradley G Whitwell; Sharon L Naismith; Ian B Hickie
Journal:  BMJ Open       Date:  2013-02-04       Impact factor: 2.692

9.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12

10.  Manitoba mothers and fetal alcohol spectrum disorders study (MBMomsFASD): protocol for a population-based cohort study using linked administrative data.

Authors:  Deepa Singal; Marni Brownell; Ana Hanlon-Dearman; Dan Chateau; Sally Longstaffe; Leslie L Roos
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.